Table 2.

Characteristics of the 165 patients with AIDS and cytomegalovirus (CMV) retinitis in the study population.

Characteristic, parameter	Value
Age, median (IQR), years	38 (34–43)
Sex, % of patients
Male	64.2
Female	35.8
Race, % of patients
White	34.0
Nonwhite	66.0
Time since AIDS diagnosis, median (IQR), months	27 (11–54)
CD4+ T cell count,a median (IQR), cells/μL	13 (5–32)
HAART received, % of patients
At diagnosis of CMV retinitis	45.1
Ever during follow-up	79.4
Initial CMV treatment received, % of patients
Systemic therapy only	47.5
Ganciclovir implant only	18.6
Ganciclovir implant and systemic therapy	32.7
Ganciclovir implant received at any time, % of patients	66.1
Follow-up, mean ± SD, months	20.3 ± 27.6
Retinitis progression rate, %b	54
Resistance rate, %b	4

NOTE. HAART, highly active antiretroviral therapy; IQR, interquartile range.

^aAt diagnosis of CMV retinitis.

^bPer person-year.